\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Nov 18, 2009 9:00 AM EST
\n\n \n Depomed Promotes William Callahan to Vice President of Operations - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 16, 2009 9:00 AM EST
\n\n \n Depomed Ranked #13 on Deloitte's Technology Fast 500TM - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 10, 2009 9:00 AM EST
\n\n \n Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R) - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 03, 2009 4:30 PM EST
\n\n \n Depomed to Present at Merriman Curhan Ford's Investor Summit 2009 - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 29, 2009 4:30 PM EDT
\n\n \n Depomed Reports Third Quarter 2009 Financial Results - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 22, 2009 4:30 PM EDT
\n\n \n Depomed, Inc. to Announce Third Quarter 2009 Financial Results on October 29, 2009 - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 22, 2009 9:00 AM EDT
\n\n \n Depomed Announces Delivery of First Formulation to Covidien and Receipt of $500,000 Milestone Payment - Business Wire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");